Evidence map›Paper›PMID 32510776›Full record

ArticleRespirology (Carlton, Vic.)2020

Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand.

Nitin Kapur, Gillian Nixon, Philip Robinson, John Massie, Bernadette Prentice, Andrew Wilson, Sandra Schilling, Jacob Twiss, Dominic A Fitzgerald

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Respirology (Carlton, Vic.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Central sleep apnea in otherwise healthy term infants.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Nitin KapurDepartment of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, QLD, Australia.ORCID 0000-0002-8423-0596
Gillian NixonMelbourne Children's Sleep Centre, Monash Children's Hospital, Melbourne, VIC, Australia.
Philip RobinsonRespiratory and Sleep Medicine, Royal Children's Hospital, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
John MassieDepartment of Respiratory Medicine, Royal Children's Hospital, Melbourne, VIC, Australia.
Bernadette PrenticeDepartment of Respiratory Medicine, Sydney Children's Hospital, Sydney, NSW, Australia.
Andrew WilsonDepartment of Respiratory and Sleep Medicine, Princess Margaret Hospital for Children, Perth, WA, Australia.
Sandra SchillingDepartment of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, QLD, Australia.
Jacob TwissRespiratory Department, Starship Children's Hospital, Auckland, New Zealand.
Dominic A FitzgeraldDiscipline of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney and the Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Royal Children's Hospital · AUThe University of Queensland · AUMonash Children’s Hospital · AUPrincess Margaret Hospital for Children · AUStarship Children's Health · NZSydney Children's Hospital · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic neonatal lung disease (CNLD) is defined as continued need for any form of respiratory support (supplemental oxygen and/or assisted ventilation) beyond 36 weeks PMA. Low-flow supplemental oxygen facilitates discharge from hospital of infants with CNLD who are hypoxic in air and is widely used despite lack of evidence on the most appropriate minimum mean target oxygen saturations. Furthermore, there are minimal data to guide the home monitoring, titration or weaning of supplemental oxygen in these infants. The purpose of this position statement is to provide a guide for the respiratory management of infants with CNLD, with special emphasis on role and logistics of supplemental oxygen therapy beyond the NICU stay. Reflecting a variety of clinical practices and infant comorbidities (presence of pulmonary hypertension, retinopathy of prematurity and adequacy of growth), it is recommended that the minimum mean target range for SpO

Indexed as

Intensive Care Units, NeonatalRespirationAustraliaHumansInfant, NewbornInfant, Newborn, DiseasesLung DiseasesNew ZealandOximetryOxygenOxygen Inhalation TherapyPatient DischargeSleepTreatment OutcomeOxygenbronchopulmonary dysplasiaoximetryoxygenpalivizumabpremature infant

Identifiers

PMID32510776
PMCPMC7496866
OpenAlexW3032985266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.